Evolving role of SPECT/CT in neuroendocrine tumors management staging, treatment response, and follow-up

Chiara Fuccio, Elena Giulia Spinapolice, Sotirios Chondrogiannis, Anna Margherita Maffione, Giuseppe Trifiro, Patrick M. Colletti, Domenico Rubello

Research output: Contribution to journalArticlepeer-review

Abstract

The combined use of SPECT and CT strongly supports the molecular imaging of neuroendocrine tumors (NETs) with somatostatin receptor radiopharmaceuticals or with meta-iodobenzylguanidine. SPECT/CT fusion images provide potential attenuation correction, higher specificity, and accurate localization for the staging, evaluation of treatment response, and follow-up of NETs.

Original languageEnglish
JournalClinical Nuclear Medicine
Volume38
Issue number10
DOIs
Publication statusPublished - Oct 2013

Keywords

  • MIBG scintigraphy
  • Neuroendocrine tumor
  • Somatostatin receptor scintigraphy
  • SPECT/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Evolving role of SPECT/CT in neuroendocrine tumors management staging, treatment response, and follow-up'. Together they form a unique fingerprint.

Cite this